Mark F. Sander

Chief Digital & Information Officer at Xenoport

Mark Sander joined Azurity as Chief Digital & Information Officer in August 2022.

Mark has more than 25 years of experience in the pharmaceutical and healthcare industries, with company’s ranging from pre-commercial to top 10 global pharma. Previously, he held senior IT leadership roles at Kiniksa Pharmaceuticals, Teva Pharmaceuticals, Church & Dwight, Schering-Plough and Mannkind Corporation. Earlier in his career he also held positions of increasing responsibility within Manufacturing and Operations at Pfizer and Merck-Medco.

With a proven record of leading business transformation through the use of technology, Mark specializes in building bridges between IT and the business, transforming IT organizations to align with business operations, and envisioning digital solutions to drive to top and bottom-line growth.

Mark holds an MBA in International Business and Finance from the NYU Stern School of Business and a BS in Applied Mathematics (Computer Science) and Industrial Management from Carnegie Mellon University. He also serves on the Rutgers University Professional Science Master’s Program Industrial Advisory Board.


Org chart